FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2626453073> ?p ?o ?g. }

• W2626453073 abstract "Atherogenic dyslipidemia is associated with poor cardiovascular outcomes, yet markers of this condition are often ignored in clinical practice. Here, we address a clear evidence gap by assessing the prevalence and treatment of two markers of atherogenic dyslipidemia: elevated triglyceride levels and low levels of high-density lipoprotein cholesterol. This cross-sectional observational study assessed the prevalence of two atherogenic dyslipidemia markers, high triglyceride levels and low high-density lipoprotein cholesterol levels, in the study population from the European Study on Cardiovascular Risk Prevention and Management in Usual Daily Practice (EURIKA; N = 7641; of whom 51.6% were female and 95.6% were White/Caucasian). The EURIKA population included European patients, aged at least 50 years with at least one cardiovascular risk factor but no history of cardiovascular disease. Over 20% of patients from the EURIKA population have either triglyceride or high-density lipoprotein cholesterol levels characteristic of atherogenic dyslipidemia. Furthermore, the proportions of patients with one of these markers were higher in subpopulations with type 2 diabetes mellitus or those already calculated to be at high risk of cardiovascular disease. Approximately 55% of the EURIKA population who have markers of atherogenic dyslipidemia are not receiving lipid-lowering therapy. A considerable proportion of patients with at least one major cardiovascular risk factor in the primary cardiovascular disease prevention setting have markers of atherogenic dyslipidemia. The majority of these patients are not receiving optimal treatment, as specified in international guidelines, and thus their risk of developing cardiovascular disease is possibly underestimated. The present study is registered with ClinicalTrials.gov (ID: NCT00882336)." @default.
• W2626453073 created "2017-06-23" @default.
• W2626453073 creator A5001317469 @default.
• W2626453073 creator A5040616504 @default.
• W2626453073 creator A5050980807 @default.
• W2626453073 creator A5055188417 @default.
• W2626453073 creator A5055457360 @default.
• W2626453073 creator A5061290817 @default.
• W2626453073 creator A5062244421 @default.
• W2626453073 creator A5082792375 @default.
• W2626453073 creator A5089812930 @default.
• W2626453073 creator A5091912873 @default.
• W2626453073 date "2017-06-17" @default.
• W2626453073 modified "2023-10-01" @default.
• W2626453073 title "Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study" @default.
• W2626453073 cites W1969831395 @default.
• W2626453073 cites W1976428272 @default.
• W2626453073 cites W2015180813 @default.
• W2626453073 cites W2017602185 @default.
• W2626453073 cites W2020915011 @default.
• W2626453073 cites W2032130021 @default.
• W2626453073 cites W2034816798 @default.
• W2626453073 cites W2036747551 @default.
• W2626453073 cites W2049383070 @default.
• W2626453073 cites W2052740563 @default.
• W2626453073 cites W2058709767 @default.
• W2626453073 cites W2066534456 @default.
• W2626453073 cites W2075147537 @default.
• W2626453073 cites W2077247955 @default.
• W2626453073 cites W2096318148 @default.
• W2626453073 cites W2098173132 @default.
• W2626453073 cites W2107165713 @default.
• W2626453073 cites W2108018713 @default.
• W2626453073 cites W2112374514 @default.
• W2626453073 cites W2116404316 @default.
• W2626453073 cites W2122908785 @default.
• W2626453073 cites W2124481954 @default.
• W2626453073 cites W2130758409 @default.
• W2626453073 cites W2168536722 @default.
• W2626453073 cites W2169582126 @default.
• W2626453073 cites W2187413246 @default.
• W2626453073 cites W2402599050 @default.
• W2626453073 cites W2509676484 @default.
• W2626453073 cites W3001764054 @default.
• W2626453073 cites W3021659692 @default.
• W2626453073 cites W3021842026 @default.
• W2626453073 cites W65486890 @default.
• W2626453073 doi "https://doi.org/10.1186/s12872-017-0591-5" @default.
• W2626453073 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5473961" @default.
• W2626453073 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28623902" @default.
• W2626453073 hasPublicationYear "2017" @default.
• W2626453073 type Work @default.
• W2626453073 sameAs 2626453073 @default.
• W2626453073 citedByCount "75" @default.
• W2626453073 countsByYear W26264530732018 @default.
• W2626453073 countsByYear W26264530732019 @default.
• W2626453073 countsByYear W26264530732020 @default.
• W2626453073 countsByYear W26264530732021 @default.
• W2626453073 countsByYear W26264530732022 @default.
• W2626453073 countsByYear W26264530732023 @default.
• W2626453073 crossrefType "journal-article" @default.
• W2626453073 hasAuthorship W2626453073A5001317469 @default.
• W2626453073 hasAuthorship W2626453073A5040616504 @default.
• W2626453073 hasAuthorship W2626453073A5050980807 @default.
• W2626453073 hasAuthorship W2626453073A5055188417 @default.
• W2626453073 hasAuthorship W2626453073A5055457360 @default.
• W2626453073 hasAuthorship W2626453073A5061290817 @default.
• W2626453073 hasAuthorship W2626453073A5062244421 @default.
• W2626453073 hasAuthorship W2626453073A5082792375 @default.
• W2626453073 hasAuthorship W2626453073A5089812930 @default.
• W2626453073 hasAuthorship W2626453073A5091912873 @default.
• W2626453073 hasBestOaLocation W26264530731 @default.
• W2626453073 hasConcept C126322002 @default.
• W2626453073 hasConcept C134018914 @default.
• W2626453073 hasConcept C142052008 @default.
• W2626453073 hasConcept C142724271 @default.
• W2626453073 hasConcept C23131810 @default.
• W2626453073 hasConcept C2778096610 @default.
• W2626453073 hasConcept C2779134260 @default.
• W2626453073 hasConcept C2908647359 @default.
• W2626453073 hasConcept C50440223 @default.
• W2626453073 hasConcept C555293320 @default.
• W2626453073 hasConcept C71924100 @default.
• W2626453073 hasConcept C99454951 @default.
• W2626453073 hasConceptScore W2626453073C126322002 @default.
• W2626453073 hasConceptScore W2626453073C134018914 @default.
• W2626453073 hasConceptScore W2626453073C142052008 @default.
• W2626453073 hasConceptScore W2626453073C142724271 @default.
• W2626453073 hasConceptScore W2626453073C23131810 @default.
• W2626453073 hasConceptScore W2626453073C2778096610 @default.
• W2626453073 hasConceptScore W2626453073C2779134260 @default.
• W2626453073 hasConceptScore W2626453073C2908647359 @default.
• W2626453073 hasConceptScore W2626453073C50440223 @default.
• W2626453073 hasConceptScore W2626453073C555293320 @default.
• W2626453073 hasConceptScore W2626453073C71924100 @default.
• W2626453073 hasConceptScore W2626453073C99454951 @default.
• W2626453073 hasFunder F4320307770 @default.
• W2626453073 hasIssue "1" @default.
• W2626453073 hasLocation W26264530731 @default.
• W2626453073 hasLocation W262645307310 @default.

• next